- Home
- OPTN vs ZENV Comparison
OPTN vs ZENV Comparison
Compare OPTN & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- ZENV
- Stock Information
- Founded
- OPTN 2010
- ZENV 2005
- Country
- OPTN United States
- ZENV Brazil
- Employees
- OPTN N/A
- ZENV N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- ZENV Computer Software: Prepackaged Software
- Sector
- OPTN Health Care
- ZENV Technology
- Exchange
- OPTN Nasdaq
- ZENV Nasdaq
- Market Cap
- OPTN 117.6M
- ZENV 121.8M
- IPO Year
- OPTN 2017
- ZENV 2021
- Fundamental
- Price
- OPTN $0.71
- ZENV $1.47
- Analyst Decision
- OPTN Strong Buy
- ZENV
- Analyst Count
- OPTN 2
- ZENV 0
- Target Price
- OPTN $4.00
- ZENV N/A
- AVG Volume (30 Days)
- OPTN 516.5K
- ZENV 19.7K
- Earning Date
- OPTN 11-07-2024
- ZENV 11-14-2024
- Dividend Yield
- OPTN N/A
- ZENV N/A
- EPS Growth
- OPTN N/A
- ZENV N/A
- EPS
- OPTN N/A
- ZENV N/A
- Revenue
- OPTN $75,058,000.00
- ZENV $158,405,865.00
- Revenue This Year
- OPTN $24.44
- ZENV $20.81
- Revenue Next Year
- OPTN $49.00
- ZENV $10.70
- P/E Ratio
- OPTN N/A
- ZENV N/A
- Revenue Growth
- OPTN 3.91
- ZENV 20.93
- 52 Week Low
- OPTN $0.65
- ZENV $0.80
- 52 Week High
- OPTN $2.10
- ZENV $3.88
- Technical
- Relative Strength Index (RSI)
- OPTN 33.40
- ZENV 41.24
- Support Level
- OPTN $0.65
- ZENV $1.45
- Resistance Level
- OPTN $0.70
- ZENV $1.54
- Average True Range (ATR)
- OPTN 0.05
- ZENV 0.07
- MACD
- OPTN -0.00
- ZENV 0.01
- Stochastic Oscillator
- OPTN 24.67
- ZENV 34.21
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.